134 related articles for article (PubMed ID: 34181873)
1. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
[TBL] [Abstract][Full Text] [Related]
2. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
[TBL] [Abstract][Full Text] [Related]
3. Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice.
Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Vargas CR; Leipnitz G; Santamaría A; Souza DO; Wajner M
Neurotox Res; 2018 Apr; 33(3):593-606. PubMed ID: 29235064
[TBL] [Abstract][Full Text] [Related]
4. Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.
Busanello EN; Fernandes CG; Martell RV; Lobato VG; Goodman S; Woontner M; de Souza DO; Wajner M
J Neurol Sci; 2014 Nov; 346(1-2):260-7. PubMed ID: 25241940
[TBL] [Abstract][Full Text] [Related]
5. Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.
Olivera-Bravo S; Ribeiro CA; Isasi E; Trías E; Leipnitz G; Díaz-Amarilla P; Woontner M; Beck C; Goodman SI; Souza D; Wajner M; Barbeito L
Hum Mol Genet; 2015 Aug; 24(16):4504-15. PubMed ID: 25968119
[TBL] [Abstract][Full Text] [Related]
6. Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum-Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate.
Seminotti B; Brondani M; Ribeiro RT; Leipnitz G; Wajner M
Mol Neurobiol; 2022 Aug; 59(8):4839-4853. PubMed ID: 35639256
[TBL] [Abstract][Full Text] [Related]
7. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
[TBL] [Abstract][Full Text] [Related]
8. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I.
Guerreiro G; Diaz Jaques CE; Wajner M; Vargas CR
Int J Dev Neurosci; 2020 Feb; 80(1):42-49. PubMed ID: 31910296
[TBL] [Abstract][Full Text] [Related]
10. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
[TBL] [Abstract][Full Text] [Related]
11. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
[TBL] [Abstract][Full Text] [Related]
12. Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Seminotti B; da Silva JC; de Oliveira FH; Ribeiro RT; Leipnitz G; Souza DO; Wajner M
Neurochem Int; 2019 Oct; 129():104467. PubMed ID: 31121257
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.
Amaral AU; Seminotti B; Cecatto C; Fernandes CG; Busanello EN; Zanatta Â; Kist LW; Bogo MR; de Souza DO; Woontner M; Goodman S; Koeller DM; Wajner M
Mol Genet Metab; 2012 Nov; 107(3):375-82. PubMed ID: 22999741
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
[TBL] [Abstract][Full Text] [Related]
16. Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I.
Vendramin Pasquetti M; Meier L; Loureiro S; Ganzella M; Junges B; Barbieri Caus L; Umpierrez Amaral A; Koeller DM; Goodman S; Woontner M; Gomes de Souza DO; Wajner M; Calcagnotto ME
Epilepsia; 2017 Oct; 58(10):1771-1781. PubMed ID: 28762469
[TBL] [Abstract][Full Text] [Related]
17. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model.
Wajner M; Amaral AU; Leipnitz G; Seminotti B
Int J Dev Neurosci; 2019 Nov; 78():215-221. PubMed ID: 31125684
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress, Disrupted Energy Metabolism, and Altered Signaling Pathways in Glutaryl-CoA Dehydrogenase Knockout Mice: Potential Implications of Quinolinic Acid Toxicity in the Neuropathology of Glutaric Acidemia Type I.
Seminotti B; Amaral AU; Ribeiro RT; Rodrigues MDN; Colín-González AL; Leipnitz G; Santamaría A; Wajner M
Mol Neurobiol; 2016 Nov; 53(9):6459-6475. PubMed ID: 26607633
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility to quinolinic acid-induced seizures and long-term changes in brain oscillations in an animal model of glutaric acidemia type I.
Barbieri Caus L; Pasquetti MV; Seminotti B; Woontner M; Wajner M; Calcagnotto ME
J Neurosci Res; 2022 Apr; 100(4):992-1007. PubMed ID: 34713466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
